Patent applications published 3 November 2010
Selected patent applications from the weekly European Patents Bulletin
- Tricyclic compounds as modulators of TNF-synthesis and as PDE4 inhibitors
High Point Pharmaceuticals 2244574*
- Angiotensin II receptor antagonists
Merck Sharp & Dohme 2244575*
- 3,5-substituted-1,3-oxazolidin-2-one derivatives
Merck Sharp & Dohme 2244576*
- Quinolizidinone M1 receptor positive allosteric modulators
Merck Sharp & Dohme 2244577*
- Inhalation drug products, systems and uses
Schering 2244692*
- Agent for intra-articular injection
Kief, Horst 2244693*
- Therapeutic compsns comprising an amine-containing lipid and a protein
Shire Human Genetic Therapies 2244694*
- Compsns for inducing immune responses
Novartis 2244695*
- Carrier pellets, method for the production thereof and use thereof
IPC Process-Center; ADD Technologies 2244696*
- Therapeutic compsns
Shire Human Genetic Therapies 2244697*
- Biodegradable therapeutic nanoparticles containing an antimicrobial agent
The University of North Caroline at Charlotte Office of Technology Transfer 2244698*
- Edible film-strips for immediate release of active ingredients
McNiel-PPC 2244699*
- Stromal interacting molecule knockout mouse and uses thereof
Immune Disease Institute 2244700*
- Corroles for Neuroprotection and Neurorescue
Tecnion Research and Development Foundation 2244701*
- Treatment of neural diseases or conditions
The Royal Institution for the Advancement of Learning/McGill University 2244702*
- Pharmaceuticals and the production and use thereof in the treatment of painful neuropathies
PAZ Arzneimittel-Entwicklungsgesellschaft 2244703*
- Treatment of aspirin resistance with betaine and/or betaine enriched molasses
Messadek, Jallal 2244704*
- Novel crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid
AstraZeneca 2244705*
- Glucokinase activators
Merck Patent 2244706*
- Tetrahydrocyclopena/c acridine derivatives as kinase inhibitors and biological applications thereof
Centre National de la Recherche Scientifique 2244707*
- New 2,3,4,5-tetrahydro-1H-pyrido[4,3-B]indole compounds and methods of use thereof
Medication Technologies 2244708*
- Topical formulations for the treatment of psoriasis
Synta Pharmaceuticals 2244709*
- A method for administering a PDE3 inhibitor via titration for the treatment of peripheral arterial disease
Indigo Pharmaceuticals 2244710*
- Certain chemical entities, compsns and methods
Cytokinetics 2244711*
- In vivo studies of crystalline forms of meloxicam
Thar Pharmaceuticals 2244712*
- Use of a gamma secretase inhibitor for treating cancer
F Hoffmann-La Roche 2244713*
- Use of picoplatin and bevacizumab to treat colorectal cancer
Poniard Pharmaceuticals 2244714*
- Peptides having a binding affinity to an antibody which recognises an epitope on an 1 loop 2 or 2 loop 1 of an adrenoreceptor
Mdc Max-Delbruck-Centrum Für Moleckulare Medizin Berlin 2244718*
- Wound healing peptides and methods of use thereof
Tufts University 2244719*
- Polypeptide vaccine and vaccination strategy against mycobacterium
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 2244720*
- Sulphone substituted 2,3-dihydroimidazo-[1,2-C]-quinazoline derivatives useful for treating hyperproliferative disorders and diseases with angiogenesis
Bayer Schering Pharma 2244721*
- Treatment of microbial infections
The Provost Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth Near Dublin 2244722*
- Compsns and methods for treating diseases associated with angiogenesis and inflammation
Chang, Chiwen 2244723*
- Use of peptides to promote wound healing
Vereniging voor Christelijk Hoger Onderwijs 2244724*
- Novel peptides and protein and uses thereof
Agency for Science, Technology and Research, Singapore 2244725*
- Use of Factor VIIa for Factor VIIa equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following an intracerebral haemorrhage (ICH) in a selected subpopulation of ICH patients
Novo Nordisk 2244726*
- A method for restoring BMP-receptor signalling in a cell
Freie Universität Berlin 2244727*
- Use of serine protease inhibitors in the treatment of skin diseases
Dermadis; Institut National de la Sante et de la Recherche Medicale 2244728*